Balyasny Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Other funds holding HCA
VCM
VPM
Balyasny Asset Management's HCA Position: Q1 2026 in Review
Balyasny Asset Management reduced its HCA Healthcare (HCA) stake by 48% in Q1 2026, selling an estimated $1.15M and leaving 2,508 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2013.
Balyasny Asset Management first reported a position in HCA in Q2 2013 and has held it in 41 quarters since. The position peaked at $63.9M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Balyasny Asset Management held 2,508 shares of HCA Healthcare worth $1.19M as of Q1 2026.
- Balyasny Asset Management sold 2,280 HCA Healthcare shares in Q1 2026, an estimated $1.15M.
- HCA Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2013 holding.
- Balyasny Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 41 quarters since.
- Balyasny Asset Management's HCA Healthcare position peaked at $63.9M in Q4 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.